4basebio PLC Share Price
Stocks
4BB
GB00BMCLYF79
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
London S.E.
10:05:29 13/11/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 525.00 GBX | 0.00% |
|
-0.94% | -14.63% |
| 16/10 | 4basebio fundraise; Geo Exploration secures grants | AN |
| 15/10 | 4basebio Targets at Least GBP15 Million from Share Sale | MT |
| Market Cap | 8.16Cr 11Cr 9.78Cr 9.04Cr 15Cr 1.02TCr 16Cr 108.61Cr 43Cr 543.31Cr 40Cr 40Cr 1.72TCr | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 8.38Cr 11Cr 10Cr 9.28Cr 16Cr 1.04TCr 16Cr 111.53Cr 44Cr 557.88Cr 42Cr 41Cr 1.77TCr | EV / Sales 2026 * |
84.2x | EV / Sales 2027 * | 21.1x |
| Free-Float |
50.52% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| 4BB | Delayed | |
BOERSE DUESSELDORF
| 88Q | End-of-day quote | |
|
Xetra
| 88Q | Delayed | |
|
Boerse Muenchen
| 88Q | Real-time | |
|
Deutsche Boerse AG
| 88Q | Delayed | |
|
Börse Stuttgart
| 88Q | Delayed |
| 1 week | -0.94% | ||
| Current month | -0.94% | ||
| 1 month | -6.67% | ||
| 3 months | -4.55% | ||
| 6 months | +20.69% | ||
| Current year | -14.63% |
| 1 week | 500 |  | 550 |
| 1 month | 495 | | 560 |
| Current year | 420 | | 630 |
| 1 year | 420 | | 725 |
| 3 years | 420 | | 1,820 |
| 5 years | 390 | | 1,820 |
| 10 years | 175 | | 1,820 |
| Manager | Title | Age | Since |
|---|---|---|---|
Amy Walker
CEO | Chief Executive Officer | 33 | 10/02/2026 |
Daniel Jones
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/2025 |
Scott Lorimer
COO | Chief Operating Officer | - | 12/03/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Heikki Lanckriet
BRD | Director/Board Member | 48 | 22/12/2020 |
Amy Walker
BRD | Director/Board Member | 33 | 08/08/2024 |
| Chairman | 60 | 08/07/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 21/05/26 | Buy | Chief Executive Officer | 1,863 | 0.0120% | ||
| 16/02/26 | Buy | Chief Executive Officer | 2,650 | 0.0171% | ||
| 11/02/26 | Buy | Director | 3,000 | 0.0193% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -0.94% | -26.32% | -0.94% | 11Cr | |
| -2.69% | -0.48% | +53.97% | +70.99% | 6.63TCr | |
| -0.92% | +7.67% | +12.64% | +92.55% | 6.06TCr | |
| 0.00% | +0.39% | +22.34% | +90.83% | 5.55TCr | |
| +0.14% | +2.35% | +13.86% | +106.64% | 4.76TCr | |
| -2.21% | -2.47% | +20.18% | +32.24% | 4.37TCr | |
| -2.30% | -10.40% | +154.30% | +725.54% | 3.73TCr | |
| +2.15% | +1.42% | +14.58% | +54.23% | 3.66TCr | |
| -2.32% | -2.24% | +76.50% | +54.55% | 3.22TCr | |
| +2.62% | +5.90% | -37.29% | +393.72% | 2.66TCr | |
| Average | -0.55% | -0.05% | +30.48% | +162.03% | 4TCr | |
| Weighted average by Cap. | -0.83% | +0.20% | +36.61% | +155.21% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10L 13.15L 11.92L 11.02L 18.74L 12Cr 19.4L 1.32Cr 52.51L 6.62Cr 49.36L 48.31L 21Cr | 48.39L 63.99L 57.99L 53.64L 91.2L 60Cr 94.42L 6.44Cr 2.55Cr 32Cr 2.4Cr 2.35Cr 102.31Cr |
| Net income | -1.82Cr -2.41Cr -2.18Cr -2.02Cr -3.43Cr -226.92Cr -3.55Cr -24Cr -9.61Cr -121.21Cr -9.03Cr -8.84Cr -384.77Cr | - |
| Net Debt | 21.88L 28.93L 26.22L 24.25L 41.23L 27Cr 42.68L 2.91Cr 1.16Cr 15Cr 1.09Cr 1.06Cr 46Cr | 2.05Cr 2.71Cr 2.46Cr 2.27Cr 3.87Cr 255.72Cr 4Cr 27Cr 11Cr 136.6Cr 10Cr 9.96Cr 433.6Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/26/13 | GBX 525.00 | 0.00% | 501 |
| 12/26/12 | GBX 525.00 | 0.00% | 0 |
| 11/26/11 | GBX 525.00 | 0.00% | 0 |
| 10/26/10 | GBX 525.00 | 0.00% | 451 |
| 09/26/09 | GBX 525.00 | -0.94% | 1,023 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 4BB Stock
Select your edition
All financial news and data tailored to specific country editions
